Dechra Pharmaceuticals gets FDA approval for first U.S. generic entrant antibiotic
Saturday, September 10, 2016
Dechra is pleased to announce that it has received approval from the U.S. Food and Drug Administration (FDA) for a generic antibiotic.
The product is expected to be a first generic market entrant in a substantial antibiotic market.
It is the first registration Dechra has achieved through Putney's development pipeline since it acquired the US-based business.
Source : reuters.com
